Related Experiment Video
Updated: Jul 1, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
COVID-19 Infection and Clinical Outcomes in Hospitalized Patients With Rheumatoid Arthritis: Insights From the
Monique G Davis1, Anum Akhlaq2, Sameen Aamer3
1Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Patients with rheumatoid arthritis (RA) face higher in-hospital mortality from COVID-19. This study highlights increased risks for RA patients, emphasizing the need for targeted research and improved care strategies for this vulnerable group.
Area of Science:
- Infectious Diseases
- Rheumatology
- Critical Care Medicine
Background:
- Coronavirus-19 (COVID-19) primarily affects the respiratory system but can impact multiple organs and exacerbate autoimmune conditions.
- Patients with autoimmune diseases, particularly rheumatoid arthritis (RA), are at increased risk for severe COVID-19 infection and complications.
- Limited large-scale studies exist on COVID-19 outcomes specifically within the rheumatoid arthritis patient population.
Purpose of the Study:
- To compare in-hospital mortality and other critical outcomes between COVID-19 patients with and without rheumatoid arthritis.
- To evaluate the impact of rheumatoid arthritis on the severity and complications of COVID-19 hospitalization.
- To identify specific risk factors and outcomes for rheumatoid arthritis patients diagnosed with COVID-19.
Main Methods:
- A retrospective analysis of the National Inpatient Sample database from January 1 to December 31, 2020.
- Inclusion of 1,050,040 adult hospitalizations: 21,545 with COVID-19 and RA, and 1,028,495 with COVID-19 but without RA.
- Primary outcome: in-hospital mortality. Secondary outcomes included mechanical ventilation, vasopressor use, cardiac arrest, cardiogenic shock, acute kidney injury, and length of stay.
Main Results:
- COVID-19 patients with RA exhibited significantly higher in-hospital mortality (12.9%) compared to those without RA (11.1%) (aOR: 1.2; p < 0.001).
- The RA cohort experienced significantly increased rates of mechanical ventilation, vasopressor use, and cardiogenic shock.
- Secondary analysis indicated a correlation between age and in-hospital mortality and mechanical ventilation rates in COVID-19 patients.
Conclusions:
- Rheumatoid arthritis is associated with significantly worse outcomes, including increased mortality, among hospitalized COVID-19 patients.
- The findings underscore the vulnerability of RA patients to severe COVID-19 complications.
- Further large-scale research is crucial to develop targeted strategies for improving outcomes in this high-risk patient subset.
Related Concept Videos
Pneumonia III: Complications and Assessment
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
The JAK-STAT Signaling Pathway
Pneumonia II: Pathophysiology

